Mediclinic International plc South African B-BBEE Act: Annual Compliance Report (6666S)
27 June 2018 - 9:00PM
UK Regulatory
TIDMMDC
RNS Number : 6666S
Mediclinic International plc
27 June 2018
Mediclinic International plc
(Incorporated in England and Wales)
Company Number 8338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
("Mediclinic" or "the Company")
27 June 2018
BROAD-BASED BLACK ECONOMIC EMPOWERMENT ACT: ANNUAL COMPLIANCE
REPORT
In accordance with the JSE Listings Requirements, applicable to
the Company having a secondary listing on the JSE, notice is hereby
given that the Company's annual compliance report in terms of
section 13G(2) of the South African Broad-Based Black Economic
Empowerment Act, 53 of 2003, as amended, (the "B-BBEE Act") was
submitted to the Broad-Based Black Economic Empowerment Commission
(the "BEE Commission"). The compliance report is available in the
governance section of Mediclinic's website at
www.mediclinic.com.
The compliance report relates to the assessment of the
broad-based black economic empowerment status of Mediclinic
Southern Africa (Pty) Ltd, a wholly-owned subsidiary of the
Company, in respect of the Company's operations in South
Africa.
About the B-BBEE Act
The B-BBEE Act was enacted to establish a legislative framework
for the promotion of broad-based black economic empowerment in
South Africa and is intended to encourage transformation by
including black people in the economy. It covers aspects such as
ownership, management control, skills development, enterprise and
supplier development and social-economic development. Although
compliance with the B-BBEE Act and the Codes of Good Practice
issued in terms thereof is voluntary, an obligation was introduced
by way of an amendment to the B-BBEE Act in 2013, which became
effective in June 2016, to require public companies listed on the
JSE to report on their broad-based black economic empowerment
status to the BEE Commission.
About Mediclinic International plc
Mediclinic is an international private healthcare services group
with operating divisions in Switzerland, Southern Africa (South
Africa and Namibia) and the United Arab Emirates. Its core purpose
is to enhance the quality of life of patients by providing acute
care, specialist-orientated, multi-disciplinary healthcare
services. Mediclinic also holds a 29.9% interest in Spire
Healthcare Group plc, an LSE-listed and UK-based private healthcare
group.
Mediclinic comprises 75 hospitals and 28 clinics. Hirslanden
operates 17 private acute care facilities and 4 clinics in
Switzerland with more than 1 800 inpatient beds; Mediclinic
Southern Africa operates 49 hospitals and 2 day clinics throughout
South Africa and 3 hospitals in Namibia with more than 8 100
inpatient beds in total; and Mediclinic Middle East operates 6
hospitals and 22 clinics with more than 700 inpatient beds in the
United Arab Emirates.
Mediclinic has a primary listing on the Main Market of the LSE
in the United Kingdom, with secondary listings on the JSE in South
Africa and the NSX in Namibia.
For further information, please contact:
Company Secretary, Link Company Matters Limited
Jayne Meacham / Caroline Emmet
+44 (0)20 7954 9569
Investor Relations, Mediclinic International plc
James Arnold, Head of Investor Relations
ir@mediclinic.com
+44 (0)20 3786 8181
Media queries
FTI Consulting
Brett Pollard/Debbie Scott - UK
+44 (0)20 3727 1000
Sherryn Schooling - South Africa
+27 (0)21 487 9000
Registered address: 6(th) Floor, 65 Gresham Street, London, EC2V
7NQ, United Kingdom
Website: www.mediclinic.com
Joint corporate brokers: Morgan Stanley & Co International
plc and UBS Investment Bank
JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank
Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
MSCFFMFTMBBTBMP
(END) Dow Jones Newswires
June 27, 2018 07:00 ET (11:00 GMT)
Mediclinic (LSE:MDC)
Historical Stock Chart
From Apr 2024 to May 2024
Mediclinic (LSE:MDC)
Historical Stock Chart
From May 2023 to May 2024